Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q2839669
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010825.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q2839669
|
035
|
|
|
‡a
(OCoLC)Q2839669
|
043
|
|
|
‡c
FR
|
046
|
|
|
‡f
17420823
‡g
18160115
|
100
|
0 |
|
‡a
Alphonse-Louis Leroy
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
0 |
|
‡a
Alphonse-Louis Leroy
‡c
French physician
‡9
en
|
400
|
0 |
|
‡a
الفونس دس لوروا
‡c
دكتور من فرنسا
‡9
arz
|
400
|
0 |
|
‡a
Alphonse-Louis Leroy
‡c
medico francese
‡9
it
|
400
|
0 |
|
‡a
ألفونس دس لوروا
‡c
طبيب فرنسي
‡9
ar
|
400
|
0 |
|
‡a
Alphonse-Louis Leroy
‡c
médico francés
‡9
es
|
400
|
0 |
|
‡a
Альфонс Лерой
‡c
французский медик
‡9
ru
|
400
|
0 |
|
‡a
Alphonse-Louis Leroy
‡c
Frans arts (1742-1816)
‡9
nl
|
400
|
0 |
|
‡a
Alphonse Leroy
‡c
Fransız hekim (1742 – 1816)
‡9
tr
|
400
|
0 |
|
‡a
Alphonse-Louis Leroy
‡c
metge francès
‡9
ca
|
400
|
0 |
|
‡a
Alphonse Leroy
‡c
médecin français
‡9
fr
|
400
|
0 |
|
‡a
Alphonse-Louis Leroy
‡c
mjek francez
‡9
sq
|
670
|
|
|
‡a
Author's Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy.
|
670
|
|
|
‡a
Author's Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa
|
670
|
|
|
‡a
Author's Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary Disease
|
670
|
|
|
‡a
Author's Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/BAV|ADV10870426
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/GRATEVE|257477
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/DNB|100184901
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/ISNI|000000011661665X
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/NTA|194574350
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/FAST|1452144
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/PTBNP|1638888
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/BIBSYS|3010955
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/BNF|10687774
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/BNE|XX1342110
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/viaf/66458606
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/NKC|mzk2012696998
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/LC|n 82041020
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/SUDOC|080755372
|
670
|
|
|
‡a
wikidata site links
‡u
https://fr.wikipedia.org/wiki/Alphonse-Louis_Leroy
|
670
|
|
|
‡a
wikidata site links
‡u
https://en.wikipedia.org/wiki/Alphonse_Leroy_(physician)
|
670
|
|
|
‡a
wikidata site links
‡u
https://arz.wikipedia.org/wiki/الفونس_دس_لوروا
|
670
|
|
|
‡a
wikidata site links
‡u
https://es.wikipedia.org/wiki/Alphonse-Louis_Leroy
|
670
|
|
|
‡a
wikidata site links
‡u
https://ar.wikipedia.org/wiki/ألفونس_دس_لوروا
|
919
|
|
|
‡a
antie1e2antibodiesstatuspriortherapyfavorsdirectactingantiviraltreatmentefficacy
‡A
Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy.
‡9
1
|
919
|
|
|
‡a
developmentofasimplescorebasedonhbeagandaltforselectingpatientsforhbvtreatmentinafrica
‡A
Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa
‡9
1
|
919
|
|
|
‡a
impactofnonalcoholicfattyliverdiseaseonlongtermcardiovasculareventsanddeathinchronicobstructivepulmonarydisease
‡A
Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary Disease
‡9
1
|
919
|
|
|
‡a
nonalcoholicfattyliverdiseaseinchronicobstructivepulmonarydisease
‡A
Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease
‡9
1
|
946
|
|
|
‡a
b
‡9
1
|
947
|
|
|
‡a
FR
‡9
1
|
993
|
|
|
‡a
LE ROY, Alphonse Vincent Louis Antoine.
‡t
Moyen de conserver les enfans, surtout à l'époque de la dentition
‡2
XR|VIAFWORK1103246851
‡3
worktoname
|
993
|
|
|
‡a
LE ROY, Alphonse Vincent Louis Antoine.
‡t
Moyen de conserver les enfans, surtout à l'époque de la dentition
‡l
German
‡s
(Herzog :
‡f
1786)
‡2
XR|VIAFEXP699656744
‡3
exprtoname
|
993
|
|
|
‡a
LE ROY, Alphonse Vincent Louis Antoine.
‡t
Moyen de conserver les enfans, surtout à l'époque de la dentition
‡l
German
‡f
1786
‡2
XR|VIAFEXP256614893
‡3
exprtoname
|
996
|
|
|
‡2
ISNI|0000000442370624
|
996
|
|
|
‡2
LC|n 82041020
|
996
|
|
|
‡2
NTA|072866292
|
996
|
|
|
‡2
SUDOC|071273603
|
996
|
|
|
‡2
BNC|981061085849406706
|
996
|
|
|
‡2
NTA|074601350
|
996
|
|
|
‡2
CAOONL|ncf11220755
|
996
|
|
|
‡2
NII|DA0496765X
|
996
|
|
|
‡2
SUDOC|109151968
|
996
|
|
|
‡2
BNE|XX1342110
|
996
|
|
|
‡2
ISNI|0000000460281166
|
996
|
|
|
‡2
DNB|1157620612
|
996
|
|
|
‡2
SUDOC|195716671
|
996
|
|
|
‡2
NTA|142518476
|
996
|
|
|
‡2
BNF|12544306
|
996
|
|
|
‡2
NTA|142550957
|
996
|
|
|
‡2
ISNI|0000000031570197
|
996
|
|
|
‡2
NUKAT|n 2015146333
|
996
|
|
|
‡2
NUKAT|n 2009111001
|
996
|
|
|
‡2
RERO|A003514406
|
996
|
|
|
‡2
SUDOC|034718001
|
996
|
|
|
‡2
SUDOC|083215212
|
996
|
|
|
‡2
RERO|A003514405
|
996
|
|
|
‡2
LC|n 94059246
|
996
|
|
|
‡2
BIBSYS|3010955
|
996
|
|
|
‡2
SUDOC|137141157
|
996
|
|
|
‡2
NUKAT|n 2021023881
|
996
|
|
|
‡2
NTA|192201352
|
996
|
|
|
‡2
DNB|1158995709
|
996
|
|
|
‡2
SUDOC|178477303
|
997
|
|
|
‡a
1742 1816 lived 0823 0115
‡9
1
|
998
|
|
|
‡a
Leroy, Alphonse Vincent Louis,
‡2
NTA|194574350
‡3
suggested
‡3
double date
|
998
|
|
|
‡a
Leroy, Alphonse Vincent Louis Antoine,
‡2
LC|n 82041020
‡3
suggested
|
998
|
|
|
‡a
Leroy, Alphonse Vincent Louis
‡2
BNE|XX1342110
‡3
suggested
|
998
|
|
|
‡a
Leroy
‡b
Alphonse Louis Vincent
‡2
BNF|10687774
‡3
suggested
‡3
double date
|
998
|
|
|
‡a
Leroy, Alphonse Louis Vincent,
‡2
NKC|mzk2012696998
‡3
suggested
‡3
double date
|
998
|
|
|
‡a
Leroy, Alphonse Vincent Louis Antoine,
‡2
J9U|987007346916605171
‡3
suggested
‡3
double date
|
998
|
|
|
‡a
Leroy, Alphonse
‡2
BIBSYS|3010955
‡3
suggested
‡3
viafid
|
998
|
|
|
‡a
Leroy,
‡b
Alphonse Louis Vincent,
‡2
PTBNP|1638888
‡3
suggested
‡3
double date
|
998
|
|
|
‡a
Leroy, Alphonse Louis Vincent,
‡2
SUDOC|080755372
‡3
suggested
‡3
double date
|
998
|
|
|
‡a
Leroy, Alphonse Vincent Louis
‡2
DNB|100184901
‡3
suggested
‡3
double date
|
998
|
|
|
‡a
Leroy, Alphonse Vincent Louis
‡2
ISNI|000000011661665X
‡3
suggested
‡3
double date
|
998
|
|
|
‡a
Leroy, Alphonse Louis Vincent
‡2
ISNI|000000011661665X
‡3
suggested
‡3
double date
|
998
|
|
|
‡a
Leroy, Alphonse Vincent Louis
‡2
ISNI|000000011661665X
‡3
suggested
‡3
double date
|
998
|
|
|
‡a
Leroy, Alphonse Vincent Louis Antoine
‡2
ISNI|000000011661665X
‡3
suggested
‡3
double date
|
998
|
|
|
‡a
Leroy, Alphonse
‡2
ISNI|000000011661665X
‡3
suggested
‡3
double date
|
998
|
|
|
‡a
Alphonse-Louis Leroy
‡c
médecin français
‡2
ISNI|000000011661665X
‡3
suggested
‡3
double date
|
998
|
|
|
‡a
Leroy, Alphonse Louis Vincent
‡2
ISNI|000000011661665X
‡3
suggested
‡3
double date
|
998
|
|
|
‡a
Le Roy, Alphonse
‡2
ISNI|000000011661665X
‡3
suggested
‡3
double date
|